首页> 外文期刊>American journal of clinical pathology. >Comparison of apolipoprotein B and non-high-density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis.
【24h】

Comparison of apolipoprotein B and non-high-density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis.

机译:载脂蛋白B与非高密度脂蛋白胆固醇的比较,用于根据受试者工作曲线分析确定冠状动脉疾病的风险。

获取原文
获取原文并翻译 | 示例
           

摘要

Whether or non-high-density lipoprotein cholesterol is equivalent to apolipoprotein B (apo B) for screening remains controversial. One reason for continued controversy is that most studies express results as relative risk/hazard or odds ratios based on P values that reflect diagnostic values poorly. Apo B and lipoprotein lipids were compared in 437 men. The results were evaluated by multivariate techniques and by receiver operating characteristic (ROC) curves. When analyzed by ROC curves, the difference between Apo B and lipoprotein lipids proved to be less than would be anticipated from the odds ratios. Although, after adjustment, the difference was about 14% by odds ratios, ROC analysis showed only a small difference of about 1%. These data show that clinical studies should analyze the data using an absolute measure of risk such as ROC curves rather than just relative indexes. Such a small absolute difference may also explain discrepancies between studies.
机译:用于筛选的非高密度脂蛋白胆固醇是否等于载脂蛋白B(apo B)仍存在争议。引起争议的原因之一是,大多数研究都将结果表示为基于P值的相对风险/危险或优势比,而P值无法很好地反映诊断值。比较了437名男性的Apo B和脂蛋白脂质。通过多元技术和接收器工作特性(ROC)曲线评估结果。当通过ROC曲线分析时,Apo B与脂蛋白脂质之间的差异被证明小于比值比所预期的差异。尽管经过调整后,差异的比值约为14%,但ROC分析显示差异仅为1%左右。这些数据表明,临床研究应使用绝对风险度量(例如ROC曲线)而不是相对指数来分析数据。如此小的绝对差异也可以解释研究之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号